Daiichi Sankyo to Pay $39 Million for FCA Violations

Japanese pharmaceutical company Daiichi Sankyo this month agreed to pay $39 million to the government to resolve allegations that it violated the False Claims Act by paying kickbacks to induce physicians to prescribe Daiichi drugs. “Settlements like this one show that the government will continue to pursue health care companies ...

lock iconTHIS IS MEMBERS-ONLY CONTENT. To continue reading, choose one of the options below.